PROTECT AF: Difference between revisions

PROTECT AF (view source)

218 bytes added , 29 July 2021

5,246

edits

@@ Line 40: / Line 40: @@
 ==Guidelines==
-'''AHA/ASA Stroke/TIA''' (2014, adapted)<ref>{{#pmid:24788967}}</ref>
+'''AHA/ACC/HRS focused update of the 2014 guideline''' (2019, adapted)<ref>{{#pmid: 30703431}}</ref>
-: The usefulness of closure of the left atrial appendage with the WATCHMAN device in patients with ischemic stroke or TIA and AF is uncertain (Class IIb; Level of Evidence B).
+* Percutaneous LAA occlusion may be considered in patients with AF at increased risk of stroke who have contraindications to long-term anticoagulation. (COR IIb, LOE B-NR)
+* Surgical occlusion of the LAA may be considered in patients with AF undergoing cardiac surgery, as a component of an overall heart team approach to the management of AF. (COR IIb, LOE B-NR)
 ==Design==